Navigation Links
Disease and Therapy Review: Asthma Now Available at ReportsandReports
Date:6/29/2010

DALLAS, June 29, 2010 /PRNewswire/ --

- ReportsandReports Announces it Will Carry the Disease and Therapy Review: Asthma Market Research Report in its Store.

Browse the complete Report on: http://www.reportsandreports.com/market-reports/disease-and-therapy-review-as thma/

The Asthma Disease and Therapy Review provides an overview of the disease and related conditions, with incidence and prevalence numbers and percentages for major countries worldwide, information on diagnosis, and an overview of treatment. Dosing and treatment cost information is provided for various treatment types. General information on the asthma market, as well as sales of leading drugs and therapies are provided.

Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.

    Table of Contents

    I. OVERVIEW

       Symptoms and severity

    II. INCIDENCE AND PREVALENCE

    Incidence Table (US, Italy)
    Prevalence Table (US, Canada, Mexico, England, UK, France, Germany,
                      Italy, Spain, China, India, Japan, Turkey, Australia,
                      Worldwide)

    III. DIAGNOSIS AND TREATMENT

    Guidelines for diagnosis and management
    Long-term medications
    Quick-relief medications
    Approach to treatment of asthma exacerbations
    Treatment rates

    IV. DOSING AND TREATMENT COSTS

    V. MARKET SIZE

    VI. COMMENTS

    VII. REFERENCES/RESOURCES


    Browse all HealthCare Reports at
http://www.reportsandreports.com/market-research/healthcare/
    Browse all Timely Data resources Reports at
http://www.reportsandreports.com/Publishers/timely-data-resources/

Related Reports

Disease and Therapy Review: Chronic Obstructive Pulmonary Disease (COPD) (http://www.reportsandreports.com/market-reports/disease-and-therapy-review-c hronic-obstructive-pulmonary-disease/)

Disease and Therapy Review: Gastroesophageal Reflux Disease (GERD) (http://www.reportsandreports.com/market-reports/disease-and-therapy-review-g astroesophageal-reflux-disease-ger/)

Disease and Therapy Review: Bladder Cancer ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-bl adder-cancer/)

Disease and Therapy Review: Colorectal Cancer ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-co lorectal-cancer/)

Disease and Therapy Review: Impetigo ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-im petigo/)

Disease and Therapy Review: Onychomycosis ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-on ychomycosis/)

Disease and Therapy Review: Ulcerative Colitis ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-ul cerative-colitis/)

Disease and Therapy Review: Hypercholesteremia ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-hy percholesteremia/)

Disease and Therapy Review: Generalized Anxiety Disorder (GAD) (http://www.reportsandreports.com/market-reports/disease-and-therapy-review-g eneralized-anxiety-disorder-gad/)

Disease and Therapy Review: Insomnia ( http://www.reportsandreports.com/market-reports/disease-and-therapy-review-in somnia/)

About Us

ReportsandReports comprises an online library of 10,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts almost all well-known publishers of such reports across the globe. We as a third-party reseller of market research reports employ a number of marketing tools, such as press releases, email-marketing and effective search-engine optimization techniques to drive revenues for our clients. We also provide 24/7 online and offline support service to our customers.

(Due to the length of these URLs, it may be necessary to copy and paste the hyperlinks into your Internet browser's URL address field. Remove the space if one exists.)

    Contact:

    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004

    http://www.reportsandreports.com/
    http://reportsnreports.wordpress.com/
    http://reportsandreports.blogspot.com/



'/>"/>
SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Disease and Therapy Review: Bladder Cancer Now Available at ReportsandReports
2. Gastrointestinal Disorders Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohns Disease and Irritable Bowel Syndrome Markets Now Available at ReportsandReports
3. Type 2 Diabetes Patients With Long-Standing Disease Achieved Glycemic Control When BYETTA(R) Was Added to Lantus(R)
4. Shire Receives CHMP Positive Opinion for VPRIV(TM) (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease in the European Union
5. Research from Rensselaer Polytechnic Institute professor offers clues to Alzheimers disease
6. New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinsons Disease
7. BioCrossroads Invests in Indianapolis Biotech Company Developing Treatments for Alzheimers Disease
8. Zymes’ Water Soluble CoQ10 Decreases Symptoms in Animal Models of Parkinson’s Disease
9. EnVivo Initiates Phase IIb Alzheimers Disease Trial For EVP-6124
10. New inhalable measles vaccine may lead to vaccines for other diseases
11. Latest breakthroughs in technology expand options for diagnosing and treating disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... , ... April 21, 2017 , ... ... related applications were the focus of researchers, engineers, product developers, and industry suppliers ... Anaheim. , Sponsored by SPIE, the international society for optics and photonics ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... to nourishing a range of emerging bio and technology start-ups, is hosting “Celebration ... 2017. This double event will start with libations and networking at 3:30 p.m. ...
(Date:4/20/2017)... ... April 20, 2017 , ... ... this new webinar will explore challenging patient cases when screening for direct oral ... there may be a need for bridging parental anticoagulation especially for those at ...
(Date:4/20/2017)... INDIANAPOLIS , April 20, 2017  Eli Lilly ... Phase 2 data evaluating galcanezumab for the prevention of ... meeting, which will take place April 22-28, 2017, in ... will present four abstracts at AAN, including safety and ... and factors associated with a reduction in monthly migraine ...
Breaking Biology Technology:
(Date:4/19/2017)... ALBANY, New York , April 19, 2017 /PRNewswire/ ... highly competitive, as its vendor landscape is marked by ... in the market is however held by five major ... and Safran. Together these companies accounted for nearly 61% ... majority of the leading companies in the global military ...
(Date:4/17/2017)... 17, 2017 NXT-ID, Inc. (NASDAQ: NXTD ... filing of its 2016 Annual Report on Form 10-K on Thursday ... ... available in the Investor Relations section of the Company,s website at ... website at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):